NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-38723
Issuer: Tiziana Life Sciences plc
Exchange: Nasdaq Stock Market LLC
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
Address: 9th Floor, 107 Cheapside
London,
UNITED KINGDOM
EC2V 6DN
Telephone number: +44 (0) 207 495 2379
(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
Tiziana Life Sciences plc American Depositary Shares
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
o 17 CFR 240.12d2-2(a)(1)
o 17 CFR 240.12d2-2(a)(2)
x 17 CFR 240.12d2-2(a)(3)
o 17 CFR 240.12d2-2(a)(4)
o  Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
o  Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
Pursuant to the requirements for the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
2021-10-20ByTara PettaAVP - Securities Operations
Date NameTitle
1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
Tiziana Life Sciences (NASDAQ:TLSA)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024 Plus de graphiques de la Bourse Tiziana Life Sciences
Tiziana Life Sciences (NASDAQ:TLSA)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024 Plus de graphiques de la Bourse Tiziana Life Sciences

Actualités Tiziana Life Sciences Plc

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mardi 11 Juin 2024 ( il y a 2 semaines) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Jeudi 6 Juin 2024 ( il y a 3 semaines) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mardi 4 Juin 2024 ( il y a 3 semaines) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Jeudi 30 Mai 2024 ( il y a 4 semaines) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Lundi 13 Mai 2024 ( il y a 1 mois) • Edgar (US Regulatory)
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Vendredi 10 Mai 2024 ( il y a 2 mois) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mardi 5 Mars 2024 ( il y a 4 mois) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Lundi 8 Janvier 2024 ( il y a 6 mois) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Vendredi 5 Janvier 2024 ( il y a 6 mois) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Vendredi 5 Janvier 2024 ( il y a 6 mois) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Vendredi 29 Décembre 2023 ( il y a 6 mois) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mardi 19 Décembre 2023 ( il y a 6 mois) • Edgar (US Regulatory)

Plus d'articles sur Tiziana Life Sciences Plc